1.
To Study the Clinical Efficacy and Safety of Remdesivir in Hospitalized Adult Patients with Moderate-to-Severe COVID-19 Disease in ICU of a Tertiary Center in Bihar. IJCP [Internet]. 2022 Apr. 15 [cited 2025 Apr. 6];32(11):20-3. Available from: https://ojs.ijcp.in/index.php/IJCP/article/view/479